Literature DB >> 18347341

PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis.

Amandine Ginouvès1, Karine Ilc, Nuria Macías, Jacques Pouysségur, Edurne Berra.   

Abstract

Cell adaptation to changes in oxygen (O(2)) availability is controlled by two subfamilies of O(2)-dependent enzymes: the hypoxia inducible factor (HIF)-prolyl and asparaginyl hydroxylases [prolyl hydroxylases domain (PHDs) and factor inhibiting HIF (FIH)]. These oxygen sensors regulate the activity of the HIF, a transcriptional complex central in O(2) homeostasis. In well oxygenated cells, PHDs hydroxylate the HIFalpha subunits, thereby targeting them for proteasomal degradation. In contrast, acute hypoxia inhibits PHDs, leading to HIFalpha stabilisation. However, here we show that chronic hypoxia induces HIF1/2alpha"desensitization" in cellulo and in mice. At the basis of this general adaptative mechanism, we demonstrate that chronic hypoxia not only increases the pool of PHDs but also overactivates the three PHD isoforms. This overactivation appears to be mediated by an increase in intracellular O(2) availability consequent to the inhibition of mitochondrial respiration. By using in cellulo and in vivo siRNA, we found that the PHDs are the key enzymes triggering HIFalpha desensitization, a feedback mechanism required to protect cells against necrotic cell death and thus to adapt them across a chronic hypoxia. Hence, PHDs serve as dual enzymes, for which inactivation and later overactivation is necessary for cell survival in acute or chronic hypoxia, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347341      PMCID: PMC2290777          DOI: 10.1073/pnas.0705680105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation.

Authors:  C Forcet; X Ye; L Granger; V Corset; H Shin; D E Bredesen; P Mehlen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

2.  HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.

Authors:  Cynthia Trastour; Emmanuel Benizri; Francette Ettore; Alain Ramaioli; Emmanuel Chamorey; Jacques Pouysségur; Edurne Berra
Journal:  Int J Cancer       Date:  2007-04-01       Impact factor: 7.396

Review 3.  pHi, aerobic glycolysis and vascular endothelial growth factor in tumour growth.

Authors:  J Pouysségur; A Franchi; G Pagès
Journal:  Novartis Found Symp       Date:  2001

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1.

Authors:  D E Richard; E Berra; E Gothié; D Roux; J Pouysségur
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

7.  HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.

Authors:  Edurne Berra; Emmanuel Benizri; Amandine Ginouvès; Véronique Volmat; Danièle Roux; Jacques Pouysségur
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

8.  Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha.

Authors:  Thilo Hagen; Cormac T Taylor; Francis Lam; Salvador Moncada
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

9.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.

Authors:  David Lando; Daniel J Peet; Jeffrey J Gorman; Dean A Whelan; Murray L Whitelaw; Richard K Bruick
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

10.  Sequence determinants in hypoxia-inducible factor-1alpha for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3.

Authors:  Jianhe Huang; Quan Zhao; Sharon M Mooney; Frank S Lee
Journal:  J Biol Chem       Date:  2002-08-13       Impact factor: 5.157

View more
  97 in total

1.  Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.

Authors:  Heidi Högel; Krista Rantanen; Terhi Jokilehto; Reidar Grenman; Panu M Jaakkola
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

2.  Prolyl hydroxylase-dependent modulation of eukaryotic elongation factor 2 activity and protein translation under acute hypoxia.

Authors:  Antonio Romero-Ruiz; Lucía Bautista; Virginia Navarro; Antonio Heras-Garvín; Rosana March-Díaz; Antonio Castellano; Raquel Gómez-Díaz; María J Castro; Edurne Berra; José López-Barneo; Alberto Pascual
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

3.  Hypoxia-Inducible Factor α and Hif-prolyl Hydroxylase Characterization and Gene Expression in Short-Time Air-Exposed Mytilus galloprovincialis.

Authors:  Alessia Giannetto; Maria Maisano; Tiziana Cappello; Sabrina Oliva; Vincenzo Parrino; Antonino Natalotto; Giuseppe De Marco; Chiara Barberi; Orazio Romeo; Angela Mauceri; Salvatore Fasulo
Journal:  Mar Biotechnol (NY)       Date:  2015-08-16       Impact factor: 3.619

4.  The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.

Authors:  Daniel E Foxler; Katherine S Bridge; Victoria James; Thomas M Webb; Maureen Mee; Sybil C K Wong; Yunfeng Feng; Dumitru Constantin-Teodosiu; Thorgunnur Eyfjord Petursdottir; Johannes Bjornsson; Sigurdur Ingvarsson; Peter J Ratcliffe; Gregory D Longmore; Tyson V Sharp
Journal:  Nat Cell Biol       Date:  2012-01-29       Impact factor: 28.824

5.  Knockout of mitochondrial thioredoxin reductase stabilizes prolyl hydroxylase 2 and inhibits tumor growth and tumor-derived angiogenesis.

Authors:  Juliane Hellfritsch; Julian Kirsch; Manuela Schneider; Tamara Fluege; Markus Wortmann; Jeroen Frijhoff; Markus Dagnell; Theres Fey; Irene Esposito; Pirkko Kölle; Kristin Pogoda; José Pedro Friedmann Angeli; Irina Ingold; Peter Kuhlencordt; Arne Östman; Ulrich Pohl; Marcus Conrad; Heike Beck
Journal:  Antioxid Redox Signal       Date:  2015-04-10       Impact factor: 8.401

6.  HIF-1α ODD polypeptides increased the expression of HIF1 and VEGF in hypoxic rat cortical neuron.

Authors:  Xuemin Liu; Juan Du; Qi Xi
Journal:  Neurol Sci       Date:  2011-06-07       Impact factor: 3.307

7.  Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.

Authors:  Francesca Spinella; Laura Rosanò; Martina Del Duca; Valeriana Di Castro; Maria Rita Nicotra; Pier Giorgio Natali; Anna Bagnato
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

8.  The role of hypoxia in 2-butoxyethanol-induced hemangiosarcoma.

Authors:  Daphna Laifenfeld; Annalyn Gilchrist; David Drubin; Milena Jorge; Sean F Eddy; Brian P Frushour; Bill Ladd; Leslie A Obert; Mark M Gosink; Jon C Cook; Kay Criswell; Christopher J Somps; Petra Koza-Taylor; Keith O Elliston; Michael P Lawton
Journal:  Toxicol Sci       Date:  2009-10-07       Impact factor: 4.849

9.  Oxygen tension regulates pancreatic beta-cell differentiation through hypoxia-inducible factor 1alpha.

Authors:  Mylène Heinis; Marie-Thérèse Simon; Karine Ilc; Nathalie M Mazure; Jacques Pouysségur; Raphael Scharfmann; Bertrand Duvillié
Journal:  Diabetes       Date:  2009-12-15       Impact factor: 9.461

Review 10.  Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum.

Authors:  Susanne Schlisio
Journal:  J Cell Mol Med       Date:  2009-08-19       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.